MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more
MeVis Medical Solutions AG - Asset Resilience Ratio
MeVis Medical Solutions AG (M3V) has an Asset Resilience Ratio of -57.84% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2023)
This chart shows how MeVis Medical Solutions AG's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down MeVis Medical Solutions AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €-16.23 Million | -57.84% |
| Total Liquid Assets | €-16.23 Million | -57.84% |
Asset Resilience Insights
- Limited Liquidity: MeVis Medical Solutions AG maintains only -57.84% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
MeVis Medical Solutions AG Industry Peers by Asset Resilience Ratio
Compare MeVis Medical Solutions AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
UCrest Bhd
KLSE:0005 |
Health Information Services | 24.81% |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638 |
Health Information Services | 0.49% |
|
BIT Computer Co. Ltd
KQ:032850 |
Health Information Services | 26.87% |
|
ezCaretech Co. LTD
KQ:099750 |
Health Information Services | 16.56% |
|
SyntekaBio Inc
KQ:226330 |
Health Information Services | 26.99% |
|
Carelabs Co.Ltd
KQ:263700 |
Health Information Services | 7.01% |
|
Shanghai Kingstar Winning Software
SHE:300253 |
Health Information Services | 0.03% |
|
Longmaster Information Tech
SHE:300288 |
Health Information Services | 0.68% |
Annual Asset Resilience Ratio for MeVis Medical Solutions AG (2006–2023)
The table below shows the annual Asset Resilience Ratio data for MeVis Medical Solutions AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-09-30 | -57.84% | €-16.23 Million | €28.05 Million | -5.83pp |
| 2022-09-30 | -52.00% | €-16.23 Million | €31.20 Million | +6.93pp |
| 2021-09-30 | -58.93% | €-16.23 Million | €27.53 Million | -0.55pp |
| 2020-09-30 | -58.38% | €-16.23 Million | €27.79 Million | +9.45pp |
| 2019-09-30 | -67.83% | €-16.23 Million | €23.92 Million | -67.83pp |
| 2018-09-30 | 0.00% | €762.00 | €38.42 Million | 0.00pp |
| 2017-09-30 | 0.00% | €2.00K | €49.08 Million | -0.04pp |
| 2016-09-30 | 0.05% | €20.00K | €43.00 Million | -0.06pp |
| 2015-09-30 | 0.11% | €50.00K | €45.55 Million | -21.55pp |
| 2014-09-30 | 21.66% | €8.29 Million | €38.25 Million | +9.34pp |
| 2013-09-30 | 12.31% | €4.23 Million | €34.37 Million | +10.43pp |
| 2012-09-30 | 1.88% | €582.00K | €30.91 Million | -3.46pp |
| 2011-09-30 | 5.35% | €1.74 Million | €32.55 Million | -2.08pp |
| 2010-09-30 | 7.43% | €2.88 Million | €38.78 Million | -7.94pp |
| 2008-09-30 | 15.37% | €9.16 Million | €59.58 Million | +13.80pp |
| 2007-09-30 | 1.57% | €559.00K | €35.58 Million | -2.44pp |
| 2006-09-30 | 4.01% | €365.00K | €9.10 Million | -- |